Centiva Capital, LP Johnson & Johnson Transaction History

Centiva Capital, LP

$5.63 Billion
Q2 2024

A detailed history of Centiva Capital, LP transactions in Johnson & Johnson stock. As of the latest transaction made, Centiva Capital, LP holds 4,401 shares of JNJ stock, worth $684,223. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,401

Previous 30 14570.0%

Holding current value

$684,223

Previous $4,000 15975.0%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $631,084 - $689,656	4,371 Added 14570.0%	4,401 $643,000
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $1 Million - $1.05 Million	-6,465 Reduced 99.54%	30 $4,000
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $930,529 - $1.02 Million	6,391 Added 6145.19%	6,495 $1.02 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $3.14 Million - $3.52 Million	-20,191 Reduced 99.49%	104 $16,000
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $2.47 Million - $2.66 Million	16,017 Added 374.4%	20,295 $3.36 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $82,473 - $98,421	546 Added 14.63%	4,278 $663,000
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $2.88 Million - $3.23 Million	-17,974 Reduced 82.81%	3,732 $659,000
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $3.09 Million - $3.44 Million	19,151 Added 749.55%	21,706 $3.53 Million
Q2 2022 Aug 17, 2022	SELL	$168.19 - $186.01 $1.68 Million - $1.86 Million	-10,000 Reduced 79.65%	2,555 $436,000
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $2.09 Million - $2.32 Million	12,455 Added 12455.0%	12,555 $2.21 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $1.01 Million - $1.14 Million	-6,364 Reduced 98.45%	100 $0
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $228,437 - $253,459	1,465 Added 29.31%	6,464 $1.11 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $88,502 - $98,349	548 Added 12.31%	4,999 $791,000
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $470,784 - $504,998	2,952 Added 196.93%	4,451 $733,000
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $1.08 Million - $1.2 Million	-7,040 Reduced 82.45%	1,499 $246,000
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $1.17 Million - $1.34 Million	8,539 New	8,539 $1.34 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $11.4 Million - $12.5 Million	-81,510 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $176,340 - $212,893	1,369 Added 1.71%	81,510 $11.5 Million
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $6.73 Million - $9.33 Million	60,594 Added 309.99%	80,141 $10.5 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $1.91 Million - $2.2 Million	15,001 Added 329.98%	19,547 $2.85 Million
Q3 2019 Nov 13, 2019	BUY	$126.95 - $142.14 $577,114 - $646,168	4,546 New	4,546 $589,000
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $9.73 Million - $11.4 Million	-80,000 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$119.4 - $131.76 $9.55 Million - $10.5 Million	80,000 New	80,000 $9.71 Million

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account

Centiva Capital, LP Johnson & Johnson Transaction History